id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2015-E-2656-0003,FDA,FDA-2015-E-2656,Letter from FDA CDER to the U.S. Patent and Trademark Office,Other,Letter(s),2015-10-20T04:00:00Z,2015,10,2015-10-20T04:00:00Z,,2015-10-20T16:28:19Z,,0,0,0900006481ccfe49
FDA-2015-E-2656-0002,FDA,FDA-2015-E-2656,Letter from U.S. Patent and Trademark Office,Other,Letter(s),2015-07-27T04:00:00Z,2015,7,2015-07-27T04:00:00Z,,2015-07-27T11:58:58Z,,0,0,0900006481ba56f8
FDA-2015-E-2656-0001,FDA,FDA-2015-E-2656,Patent Extension Application from NOVARTIC PHARMACEUTICAL CORP (on behalf of IRM LLC),Other,Application,2015-07-27T04:00:00Z,2015,7,2015-07-27T04:00:00Z,,2015-07-27T11:58:52Z,,0,0,0900006481ba56fa